Mifepristone for medical abortion. Exploring a new option for nurse practitioners.
Taylor
Diana
D
Department of Family Health Care Nursing, University of California, San Francisco, USA.
Hwang
Ann C
AC
D000021:Abortifacient Agents, Steroidal / Q000009:adverse effects; D000028:Abortion, Induced / Q000009:adverse effects / Q000331:legislation & jurisprudence / Q000379:methods* / Q000451:nursing*; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects; D009722:Nurse Practitioners / Q000193:education / Q000458:organization & administration; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D013997:Time Factors; D014481:United States; D014619:Vacuum Curettage
D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone